A new acyclic diterpenoid (1) and a new erythroxan diterpenoid (2), together with 4 erythroxan diterpenoids and 3 triterpenoids, have been isolated from the aerial parts of Fagonia mollis. Their structures were elucidated on the basis of 1D and 2D NMR data. The cytotoxic activity of the isolated compounds was investigated against HL-60 cancer cells.
Fagonia mollis Del. (Zygophyllaceae) is an annual low shrub 20-40 cm high, or a perennial with a woody base [1a,b] . It grows wild in the desert east of the Nile river and in the Sinai Peninsula in Egypt [1b] . A methanolic extract of F. mollis was reported to exhibit antischistosomal activity [1c] , and the saponin mixtures of F. mollis showed anti-inflammatory, analgesic and antipyretic effects [1d] . Previous phytochemical investigations of F. mollis resulted in the isolation of flavonoid glycosides, triterpenes and saponins [2a,b] . Our investigation on the aerial parts of F. mollis resulted in the isolation of two new diterpenoids (1 and 2, Figure 1 (9) [2f]. The structure elucidations of 1 and 2, and their cytotoxic activities are described herein.
Compound 1, a white amorphous solid, was determined to be C 26 H 44 O 6 from HRESIMS data, indicating the presence of 5 doublebond equivalents. The 1 H NMR data of 1 (Table 1) showed the presence of 5 methyls, and 6 olefinic protons, and the 1 H and 13 C NMR data of 1 indicated the presence of 4 double bonds and a hexose moiety, implying the aglycone moiety of 1 to be acyclic. Further analyses of the 1 H and 13 C NMR data of the aglycone moiety of 1 revealed their similarities to those of geranyllinalool [2g], except for those in the vicinity of C-3. Therefore, 1 was assumed to be geranyllinalool-3-O-glycoside. Further analyses of the 1D and 2D-NMR (HSQC, 1 H-1 H COSY, HMBC and NOESY, Figure 2 ) data of 1, supported the structure of 1 to be geranyllinalool-3-O--glycopyranoside. The sugar moiety was suggested to be glucose based on the 13 C NMR chemical shifts; acid hydrolysis of 1 confirmed this identity as D-glucose. Unfortunately, we were unable to determine the configuration of C-3 since hydrolysis of 1 yielded a dehydration product of geranyllinalool. Thus, 1 was determined to be geranyllinalool-3-O--Dglucopyranoside.
Compound 2, a white amorphous solid, was determined to be C 20 H 34 O 3 from HRESIMS data. The 1 H and 13 C NMR spectra of 2 (Table 1) showed signals similar to those of other erythroxan diterpenoids isolated in this study, suggesting the structure of 2 to be an erythroxan diterpenoid. Furthermore, the chemical shift differences between 2 and 6, which was isolated from the same fraction, resembled those of 2-oxofagonene [3] and 2-oxo-5-epifagonene [2d], suggesting the structure of 2 to be 7-hydroxy-5-epifagonene. The planar structure of 2 was confirmed to be the same as 6 from analyses of its HSQC, 1 H-1 H COSY, and HMBC correlations ( Figure 2 ). The -orientation of C-19 was confirmed from the NOESY correlation of H 3 -19/H 3 -20. The configurations of the other chiral centers were deduced to be the same as 6 based on the 1 H and 13 C NMR chemical shifts, and NOESY correlations. combined extracts were evaporated under reduced pressure to give a residue (60 g), which was dissolved in water and partitioned with solvents of increasing polarities, n-hexane, CHCl 3 and EtOAc, to give n-hexane (9.0 g), CHCl 3 (26 g) and EtOAc fractions (2.0 g). Repeated separation and purification of the CHCl 3 fraction using silica gel (CHCl 3 /MeOH or n-hexane/EtOAc), ODS (H 2 O/MeOH), and Sephadex LH-20 (CHCl 3 /MeOH, 1:1) CC yielded fagonone (3, 25 mg, 0.005%), 2,7-dioxofagonene (5, 12.5 mg, 0.002%), fagonene (4, 6.7 mg, 0.001%), quinovic acid (7, 72.8 mg, 0.01%), quinovic acid-3-O--D-glucopyranoside (8, 24.5 mg, 0.004%), compound 1 (17.8 mg, 0.003%), and a mixture of 7β-hydroxyfagonene (6) and compound 2. The mixture was then separated by RP-HPLC (Cholester 4.6 mm x 25 cm, UV detection 210 nm, mobile phase: MeCN/H 2 O 33:77, flow-rate: 1 mL/min) to obtain pure 6 (t R 29.4 min, 1.7 mg, 0.0003%) and compound 2 (t R 35.2 min, 1.0 mg, 0.0002%). In addition, separation of the EtOAc fraction by Sephadex LH-20 (CHCl 3 /MeOH, 1:1) and ODS (H 2 O/MeOH) CC yielded 3-O-[-D-(2-O-sulfo)glucopyranosyl] quinovic acid (9, 1.1 mg, 0.000009%). (1 Acid hydrolysis of 1: 1 (1.0 mg) was treated with 1N aqueous HCl (50 μL) at 100 o C for 1 h. After neutralization with 1N aqueous NaOH, the mixture was extracted with CHCl 3 . The aqueous layer was submitted to HPLC analysis (GL science NH2 column φ 4.6 x 250 mm, eluent: 70% aqueous MeCN, flow rate 1.0 mL/min, JASCO OR-1590 chiral detector). Retention times of authentic Lglucose and D-glucose were 7.5 min with negative and positive intensity, respectively. The sugar in the aqueous layer of the hydrolysate of 1 had a retention time of 7.5 min with positive intensity. The CHCl 3 layer yielded a dehydration product of geranyllinalool.
Geranyllinalool-3-O--D-glycopyranoside
Cytotoxic activity: HL-60, human promyelocyctic leukemia cells were maintained in RPMI-1640 medium. The growth medium was supplemented with 10% fetal calf serum and 1% Penicillin-Streptomycin. The cells (5 x 10 3 cells/well) were cultured in Nunc disposable 96-well plates containing 90 µL of growth medium per well and were incubated at 37 o C in a humidified incubator of 5% CO 2 . Ten µL of serially diluted samples (50 µM, 25 µM, 12.5 µM, and 6.25 µM) were added to the cultures after 24 h of incubation. After 48 h of incubation with the samples, 15 µL of MTT (5 mg/mL) was added to each of the wells. The cultures were incubated for another 3 h before the cell supernatant was removed. Then, 50 µL of DMSO was added to each well. The formed formazan crystals were dissolved by re-suspension by pipette. The optical density was measured using a microplate reader (Bio-Rad) at 550 nm with a reference wavelength of 700 nm. In all experiment, 3 replicates were used. Cisplatin was used as positive control (IC 50 = 0.87 M). 
